Journal of Genetic Engineering and Biotechnology

Table 3 Evaluation of NAFLD mark vs non-invasive models for NAFLD

From: NAFLD mark: an accurate model based on microRNA-34 for diagnosis of non-alcoholic fatty liver disease patients

Index	AUC (95% CI)	p value	Cut-off	Sensitivity	Specificity	PPV	NPV
AAR	0.44 (0.37–0.51)	0.68	1.0	56	64	77	41
PALA	0.48 (0.41–0.55)	0.51	1.0	9	98	90	33
APRI	0.58(0.51–0.64)	0.19	0.35	59	50	72	36
FIB4	0.66 (0.60–0.73)	0.03	1.2	59	62	76	41
BARD	0.68 (0.62–0.74)	0.001	2.0	66	67	81	49
NAFLD	0.73 (0.66–0.78)	< 0.0001	1.0	51	85	88	45
BAAT	0.86 (0.82–0.91)	< 0.0001	2.0	72	100	100	63
NAFLD mark	0.98 (0.93–0.99)	< 0.0001	1.5	93	90	95	86

Back to article page